Jutta Petschenka
Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Jutta Petschenka works in Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, T-cell and B-cell Immunology, Virus-based gene therapy research, CAR-T cell therapy research. Recorded institutional associations include University Medical Center of the Johannes Gutenberg University Mainz, Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
2021 · 515 citationsCD206+ tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity
2022 · 121 citationsCD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming
2025 · 36 citationsLocal radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
2021 · 25 citationsIntravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell response
2019 · 22 citationsDetection of Mycobacterium avium ssp. paratuberculosis in ileocaecal lymph nodes collected from elderly slaughter cows using a semi-nested IS900 polymerase chain reaction
2011 · 18 citationsFLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines
2016 · 16 citationsA Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo
2018 · 16 citationsUnexpected high frequency of neurofibroma in the celiac ganglion of German cattle
2020 · 5 citationsCIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy
2015 · 1 citationsGene Therapy With a High-Affinity Single-Chain p53-Specific TCR Mediates Potent Anti-Tumor Response Without Inducing Gvhd In Vivo
2013 · 0 citationsCIMT 2016: Mechanisms of efficacy in cancer immunotherapy — Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10–12 2016, Mainz, Germany
2016 · 0 citationsAbstract 3741: Antimetastatic activity of ISTH0047, a potent and selective TGF-beta 2 antisense oligonucleotide, in syngeneic lung metastatic model of mouse 4T1 mammary carcinoma
2016 · 0 citationsSafe and Effective Adoptive T-Cell Receptor Transfer with a High Affinity Single Chain p53(264–272)-Specific TCR
2012 · 0 citationsCorrection to: Unexpected high frequency of neurofibroma in the celiac ganglion of German cattle
2020 · 0 citations2284P Pre-clinical assessment of the therapeutic potential of a CD80-Fc-armed oncolytic virus (VSV-GP-CD80Fc)
2023 · 0 citationsAbstract 6658: TcE armed oncolytic virus VSV-GP combines oncolysis and T-cell retargeting for improved efficacy
2024 · 0 citationsOS-026 CD4+T cells license Kupffer cells to produce IL-27 and reverse the CD8+T cell dysfunction induced by hepatocellular priming
2025 · 0 citationsLung-targeted cytokine-coding RNA-lipoplexes induce T and NK cell-mediated anti-tumor immune response
2026 · 0 citations
